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Tenascin-C (TNC) is a multidomain extracellular matrix protein
that contributes to organogenesis and tumorgenesis. To eluci-
date its developmental function in the context of TNC defi-
ciency, lung lobes of TNC null mice were obtained at Embryonic
Days E11.5 and E12.5 and cultured for 3 d. In lung explants
of homozygote TNC-deficient embryos (E12.5) the number of
future airway branches was reduced by 36% as compared with
wild-type. In heterozygote explants only half of the reduction
(18%) was observed. No significant alteration, neither of the
explant growth nor of the pattern of airway branching, was
noticed in TNC-null explants. However, the terminal endbuds
of the transgenic explants were enlarged. The results are sup-
ported by a morphologic investigation at Postnatal Day P2,
where the airspaces of TNC-deficient lungs appeared larger
than in wild-type lungs. Taken together, our results represent
the first developmental phenotype of TNC-null mice. We con-
clude that TNC takes part in the control of fetal lung branching,
and that not only the presence of TNC but also its amount
is important. Because TNC is predominantly expressed at the
growing tip of the future airways, we hypothesize that TNC
promotes the penetration into the surrounding mesenchyme
and the branching of the growing airways.
Lung Development
Mouse lung development comprises six different stages.
Organogenesis starts with the embryonic period (Embry-
onic Days E9.5–E12). The lung anlage forms by a ventral
outpouching of the foregut at the caudal end of the laryngo-
tracheal sulci. The two formed lung buds, will give rise to the
main bronchi (1). Cranial of the lung buds, the prospective
trachea, and esophagus form by separation from the foregut
(2). The prospective main bronchi divide dichotomously
and invade the surrounding mesenchyme forming the future
bronchi. Looking like a primitive gland, the developing lung
enters the pseudoglandular stage (E12–E16.5). Most of the
branching morphogenesis takes place during this stage. Epi-
thelial differentiation starts and the future bronchi and
bronchioli begin to acquire their smooth muscle layer. The
canalicular stage (E16.5–E17.5) is characterized by a “cana-
lization” of the future lung parenchyma by capillaries. Branch-
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ing comes to completion, the formation of the air–blood
barrier starts, and the epithelial type II cells produce the first
surfactant. During the saccular stage (E17.5–P4) terminal
clusters of widened spaces (saccules) are formed in the
peripheral airways. The capillary network surrounding the
saccules condenses and forms two capillary layers located
directly underneath both septal surfaces. As a result the
septa now contain two sheets of capillary layers separated
by a core of connective tissue. After birth, during the phase
of alveolarization (P4–P14), the alveoli are formed by lifting
off of secondary alveolar septa from the existing primary
septa. The double capillary layer of the immature alveolar
septa is reduced to a single capillary layer during the phase
of microvascular maturation (P14–P21) (3, 4).
Tenascin-C
Tenascin-C (TNC) belongs to a family of at least five large
extracellular matrix glycoproteins (tenascin-C, tenascin-R,
tenascin-W, tenascin-X, and tenascin-Y). TNC is detectable
only in small amounts in normal adult tissues. Larger
amounts are expressed during development, as well as in
adults during tissue repair and remodeling, especially during
neovascularization, wound healing, and tumorgenesis (5, 6).
Whereas tenascin-R is highly restricted to the central ner-
vous system, the expression of TNC and tenascin-X is fre-
quently reciprocal. In skin, tendons, ligaments, heart, uterus,
placenta, aorta, skeletal muscle, and nerves, expression of
tenascin-X prevails. But in fetal brain and spleen, adult
spinal cord, kidney, and in lung, TNC appears to be leading
(7, 8). Tenascin-W, the newest member of the tenascin
family, was identified in zebra fish and colocalizes with TNC
in neural crest (9). TN-Y represents the avian homolog to
mammalian tenascin-X and has been identified in heart
and skeletal muscle and in the connective tissue of skeletal
muscle (10).
The expression of TNC is upregulated by different fac-
tors like transforming growth factor 1, fibroblast growth
factor, keratinocyte growth factor, nerve growth factor, and
mechanical stress. Glucocorticoids downregulate TNC ex-
pression. TNC contributes to the regulation of cell prolifera-
tion, migration, growth, and survival during organogenesis
and tissue repair. Its developmental role is underlined by
its accumulation in the vicinity of actively growing epithe-
lia—meaning in their basement membranes and their sur-
rounding mesenchyme (11–13).
Tenascin-C during Lung Development
Throughout prenatal lung development TNC accumulates
in the basement membranes and mesenchyme surrounding
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the branching and growing tips of the bronchial tree. In
chicken TNC is expressed by epithelial cells (14), whereas in
mice and rats it is predominantly expressed by mesenchymal
cells at the sites of branching (3, 15, 16). Perturbation of fetal
lung organ cultures with functional anti-TNC antibodies or
bacterially expressed TNC fragments resulted in a reduction
of the number of branches. The growth of these explants
was not altered (16, and J.C.S., unpublished results).
Postnatally TNC is expressed at the tips of the newly
forming septa during the phase of alveolarization. In 3D
these tips represent the alveolar entrance rings (alveolar
mouths). In addition, they contain elastic fibers, collagen,
and smooth muscle cells. It is believed that they have to
bear mechanical forces. In later stages no TNC expression
was observed anymore (16).
Tenascin-C Knockout Mice
According to the described developmental role of TNC, it
was rather surprising when Saga and coworkers presented
a homozygous TNC-deficient mouse without an apparent
phenotype (17). Forsberg and colleagues repeated this ex-
periment obtaining the same result by introducing an inde-
pendently produced TNC-null mouse (18). Both mouse
strains showed no significant difference from wild-type with
respect to size, life span, or fertility. A brief histologic exam-
ination of the principal organ systems including lung did not
reveal any further phenotype. More detailed investigations
were necessary to recognize subtle phenotypes like abnor-
mal behavior (19), reduced haemopoietic activity of bone
marrow cells (20), decreased reaction on suture wounds of
cornea (21), a reduced proliferation of mesangial cells, and
abnormal restoration after habu-snake venom–induced glo-
merulonephritis (22) (for review see Ref. 11).
Due to the complexity of lung development, a lung phe-
notype may easily be overseen or an early developmental
phenotype may be rescued during later stages of develop-
ment. Therefore, we investigated lung branching morpho-
genesis in TNC null mice of Forsberg and associates (18)
using lung organ cultures.
Materials and Methods
Animals
The TNC-null mouse strain of Forsberg and coworkers was used
(18). Wild-type littermates and 129/Sv mice were used as controls.
Fetuses (12.5 d old) were obtained from heterozygote breeding;
11.5-d-old fetuses were obtained from homozygote breeding. Phe-
notyping was done according to Forsberg and colleagues (18).
Handling of the animals before and during the experiments, as
well as the experiments themselves, were approved and supervised
by the Swiss Agency for the Environment, Forests and Landscape
and the Veterinary Service of the Canton of Bern.
Lung Organ Culture
Fetal mouse lungs were obtained at Day E11.5 or E12.5 under
sterile conditions and cultured as described previously (23). At
Day E12.5 lung lobes were separated in phosphate-buffered saline
(PBS; 127 mM NaCl, 10 mM Na2HPO4, pH 7.4) and cultured
individually at the air–culture medium interface on a floating filter
(TSTP Isopore filter, 13 mm diameter, 3 m pore size; Millipore,
Figure 1. Lung organ culture. Lung lobes were obtained from
TNC-deficient (a, d, g;/), heterozygote (b, e, h;/), and wild-
type fetuses (c, f, i; /) on Embryonic Day E12.5. As compared
with wild-type, TNC-deficient and heterozygote explants devel-
oped a smaller number of branches. Organ explant growth ap-
peared unaltered, but the terminal endbuds looked larger. The
images were taken at the start of the organ culture (Hour 0; a, b,
c ), after 25 h (d, e, f ) and 48 h (g, h, i ). Bar: 0.5 mm.
Bedford, MA) in a 24-well plate (Falcon-Becton Dickinson, Lin-
coln Park, NJ) at 37C in 5% CO2/air. Lungs obtained at E11.5
were explanted undissected. The medium, Dulbecco’s modified
eagle medium (GibcoBRL-Life Technologies, Basel, Switzerland),
was enriched with 10% fetal calf serum (GibcoBRL), 5 g/ml
bovine insulin (Sigma Chemicals Co., St. Louis, MO), 2 mM gluta-
mine (Sigma), 75 g/ml streptomycin (Sigma), and 100 g/ml peni-
cillin (Sigma). Three explants were transferred onto each filter
and the filters were placed in a well containing 350 l medium.
The distance between the three explants was large enough to ensure
that the tissues did not touch during growth. The explants were
fed daily by adding 200 l of fresh medium per well. Images of
the explants were taken twice a day using an inverted microscope
(Diaphot-TMD; Nikon, Tokyo, Japan).
Statistical Evaluations
As a measure for number of branches, the number of terminal
endbuds was counted on micrographs as shown in Figure 1. The
growth (volume %) was estimated by area measurement of the
projected organ pieces. The growth was calculated by dividing
the measured area by the area of the explant at the start of the
experiment and multiplying this result by 100. We may take these
numbers as an estimation of the volume % of the growth, because
the quotient of the diameter and the thickness of the individual
explant were constant, especially as compared between different
explants at one time point, but also between explants at different
time points.
The size of the terminal endbuds was measured as follows. For
all explants obtained at Day E11.5 branching of the endbuds was
followed individually in the time interval of 15–40 h after explanta-
tion. At time point 40 h the endbuds were grouped into the catego-
ries “no branching,” “branched once,” and “branched twice,” and
their size was measured on 23 enlarged prints using a graphics
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Figure 2. Statistical evaluation of the lung organ culture results
(Figure 1). The number of branches was assessed by counting the
terminal endbuds (a ). After 48 h a significant difference between
wild-type (/), heterozygote (/), and homozygote (/)
TNC-deficient explants was observed. Area measurements of the
projected organ pieces were used to estimate the growth (volume
%). Even after 3 d no significant differences were observed (b ).
Bars include the standard deviation.
tablet of a pentium base personal computer system and the soft-
ware SigmaScan (SPSS Inc., Chicago, IL). A histogram of the
categories was drawn and the mean size of terminal endbuds was
calculated separately for homozygote null, heterozygote, and wild-
type explants.
For the estimation of the size of the airspaces at Day P2, central
paraffin sections of three TNC-null and three wild-type left lungs
were photographed in a meandering pattern covering  50% of
the section (one section per lung). The mean volume-weighted
airspace volume was estimated as described by Howard and Reed
(24). Briefly, airspaces were sampled for measuring using a grid
of points. The length of an isotopic line (l0) passing through the
sampling point that lies within the airspace transect was measured
for every selected airspace. The mean volume-weighted airspace
volume was estimated from
∧
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where n is the total number of point-sampled linear intercepts and
l0,i3 is the cube of the ith point-sampled intercept length. Because
we used this estimation only for a verification of our morphologic
observation, the ratio between homozygote TNC-deficient and
wild-type animals is given only.
For all experiments significance was determined using the Stu-
dent’s t-test. P 	 0.05 was defined as “significant” and P 	 0.001
as “highly significant.”
Transferase-Mediated dUTP Nick End Labeling Assay
and Cell Proliferation
Transferase-mediated dUTP nick end labeling (TUNEL) assay and
the immunoperoxidase staining was performed on 10-m cryostat
Figure 3. Branching pattern. The branching pattern of TNC null
(a, /) and wild-type (b, /) explants obtained at E11.5 were
compared. No difference in the branching pattern (solid lines) was
observed. Explants are shown after 30 h in culture. Additional
branches of the wild-type lung are labeled with dotted lines. Bar:
0.5 mm.
cross-sections of lung explants that were cultured for 54 h as de-
scribed by Schittny and coworkers (25, 26). Briefly, after digestion
with 5 g/ml Proteinase K (21C, 10 min) cryosections were incu-
bated with terminal transferase reaction solution, containing 9 mM
digoxigenin-11-dUTP and 0.165 U/ml enzyme (Boehringer Mann-
heim, Mannheim, Germany) for 50 min at 37C. The incorporated
digoxigenin was detected with anti-digoxigenin (rhodamine-anti-
digoxigenin from Boehringer Mannheim). Proliferating cells were
labeled using monoclonal antibody MIB-5 (Immunotech, Mar-
seilles, France) (27, 28), which was diluted 1:50 in Tris-buffered
saline/bovine serum albumin, containing 1% normal goat serum.
Endogen peroxidases were quenched by a treatment with 3%
H2O2 (30%) in methanol two times for 20 min. First antibody
was detected using biotinylated, affinity-isolated goat anti-mouse
globulin (diluted 1:200 in Tris-buffered saline; Dakopatts, Glostrup,
Denmark), followed by the visualization with avidin–biotin peroxi-
dase complex (ABC; Dakopatts) using diaminobenzidine as sub-
strate.
Morphology
Lungs were prepared according to Schittny and coworkers (25).
Briefly, at Postnatal Day P2 the pulmonary blood vessels were
perfused with PBS containing 5 U/ml heparin, 10 mg/ml procaine,
and 10 mM EDTA (Fluka Chemie AG, Buchs, Switzerland), and
the airspaces were filled with PBS containing 4% freshly prepared
paraformaldehyde (Merck, Darmstadt, Germany) at a constant
pressure of 20 cm water column. At this pressure, the lung reaches
roughly its midrespiratory volume. To prevent a recoiling of the
lung, the pressure was maintained during fixation of 1 h. After
three washes in PBS, followed by a graded series of ethanol and by
three changes of Histoclear (Life Science International, Frankfurt,
Germany), lungs were embedded in paraffin (Histosec; Merck) at
60C. Under all conditions no recoil of the lungs was observed.
3.5–5 m sections were cut, transferred onto silanized (aminopro-
pyl-trimethoxy-silane) microslides, air-dried overnight at 37C, de-
waxed in Histoclear, and stained with hematoxylin and eosin.
Volumetry
After fixation the five lobes were separated and their volumes
were measured by water displacement (29). The total lung volume
was calculated from the five lobar volumes. The specific lung vol-
ume was defined as lung volume over body weight (30).
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Figure 4. Morphometry of terminal endbuds. We determined how
often each individual endbud branched between 15 and 40 h in
culture (a ) and measured its size 40 h after the lungs were explanted
(b ). The number of terminal endbuds significantly differed be-
tween homozygote (/) TNC-deficient lung explants and wild-
type (/) or heterozygote (/) ones in the “no branching”
(P  0.003) and the “branched twice” (P  0.028) groups (a ). As
compared with wild-type the size of the endbuds was significantly
enlarged for heterozygote (P  0.004) and homozygote-null ex-
plants (P  0.001) in the “no branching” group and for homozy-
gote-null explants (P  0.022) in the “branched once” group (b ).
Some of the data of the heterozygote explants did not reach signifi-
cance due to the short interval of observation. There were no
endbuds found which branched twice in the homozygote null ex-
plants. *P 
 0.05; **P 
 0.001; n.a., not applicable. Bars include
standard errors.
Results
Lung Organ Culture
Lung organ cultures were used to compare branching mor-
phogenesis of TNC null and wild-type lungs. Fetal lungs of
TNC-deficient (18) and of wild-type embryos were ex-
planted at Days E11.5 or E12.5 and cultured for at least
3 d (Table 1). As wild-type controls 129 SV mice were used
at Day E11.5 and homozygote TNC expressing littermates
at Day E12.5.
Branching Morphogenesis and Growth
In our current study we characterized lung branching mor-
phogenesis (1) by the number of branches occurring (called
branching) and (2) by the pattern of airway branching (called
branching pattern). The number of terminal endbuds was
taken as a measure of branching. After 48 h in culture
homozygote TNC-deficient explants showed a highly sig-
Figure 5. Cell proliferation and cell death. After 54 h in culture
explants were cross-sectioned and stained for cell proliferation
(mAB MIB-5, a and b ), or programmed cell death (TUNEL, c
and d ), respectively. No difference between homozygote TNC-
deficient (a and c; /) and wild-type (b and d; /) explants
was observed.
nificant reduction of the number of endbuds as compared
with wild-type (36%, P 	 0,001, start of culture  E12.5).
In lung explants of heterozygote TNC-deficient fetuses the
number of the terminal endbuds was also reduced, but only
half of the reduction mentioned above was observed (18%,
P 	 0.002; Figures 1 and 2, Table 1). Similar results were
obtained using lungs which were explanted at Day E11.5
(Table 1). Comparing the growth of the explants, we did
not detect any significant difference between TNC null and
wild-type explants (Figures 1 and 2). However, we observed
an enlargement of the size of the terminal endbuds in
the TNC-null explants (Figures 1 and 3). The latter results
were confirmed by morphometric measurements (Figure 4).
Branching was followed for every individual terminal end-
bud between 15 and 40 h after explantation and their size
was measured at the latter time point. In the group of “no
branching” the size of the homozygote as well as of the
heterozygote TNC-deficient endbuds was roughly twice as
large as that in controls. The size of the homozygote TNC-
null endbuds which had branched once was enlarged by
 20%. In contrast to wild-type and heterozygote TNC-
deficient explants, the homozygote TNC-null explants did
not contain any endbud that branched twice during the
period of observation (Figure 4).
In vivo the branching pattern of the larger airways ap-
pears to be very constant (31). We also observed this in
our wild-type lung organ cultures, when whole lungs were
explanted at Day E11.5. As shown in Figure 3, TNC-null
explants showed the same very constant branching pattern
as the wild type up to the time point ( 3 d in culture) where
the bronchial tree became too complex to be compared.
Cell Proliferation and Cell Death
Wondering if the balance between cell proliferation and
cell death may explain the observed lung phenotype of the
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Figure 6. Lung morphology at Postnatal Day 2. Comparing the
morphology of TNC-null lungs (a; /) to wild-type lungs (b,
/) at Postnatal Day 2 (P2), the observed airspaces of the gas
exchange area appeared larger in TNC-deficient lungs than the
wild-type ones. Scale bar: 100 m.
TNC null mice, we stained cross-sections of the explants
for cell proliferation (mAB MIB-5), or programmed cell
death (TUNEL), respectively, at Day E11.5 (four explants
of each condition). No difference between homozygote
TNC-deficient and wild-type explants could be observed (Fig-
ure 5).
Lung Morphology at Postnatal Day 2
We studied the lung morphology at Postnatal Day 2 to
support our in vitro data with in vivo observations. Day P2
was chosen because at this time point branching morpho-
genesis is completed and alveolarization has not yet started
TABLE 1
Number of used explants and observed number of branches
E11.5 E12.5
No. of Explants % Branching No. of Explants % Branching
TNC / 9 54  1.8** 8 64  5.6**
TNC / — — 4 82  4.7*
TNC / 8 100  13.5 13 100  7.1
Lungs were obtained from fetuses at Embryonic Days E11.5 or E12.5, respec-
tively. The number of terminal endbuds was counted after two days in culture
and normalized to the controls. The standard deviation and the P value of the
Student’s t test were calculated.
* P 	 0.002.
** P 	 0.001.
TABLE 2
Total and specific lung volume
P2
Total Lung Volume Specific Lung Volume
TNC / 0.084  0.015 ml 0.047  0.005 ml/g body weight
TNC / 0.076  0.060 ml 0.045  0.008 ml/g body weight
No significant difference was observed between the lung volumes of TNC-
deficient and wild-type animals (P  0.35). Means of three animals per group
and standard deviations are given.
(3). Therefore, we were able to investigate the end point
of branching morphogenesis. We did not study any earlier
time point, because it would not have been possible to
distinguish between reduced or delayed branching. The to-
tal and the specific lung volumes of TNC null and wild-
type mice at Day P2 did not show any significant difference
(Table 2). But comparing the morphology of the lung paren-
chyma of TNC-deficient and wild-type lungs, we observed
an enlargement of the airspaces of the gas exchange area
in TNC-null lungs (Figure 6). This result was verified by
estimating the mean volume-weighted airspace volume. In
TNC-deficient lungs the airspace volume was estimated to
be almost two times (factor 1.85) larger than in wild-type
lungs. Because we did not detect any other morphologic
differences between knockout and wild type, the enlarged
airspaces may be taken as an in vivo confirmation of the
reduced branching observed in TNC-null lung organ cul-
tures.
Discussion
Despite the fact that many in vitro studies attributed a
developmental role to TNC, no developmental phenotype
was described in TNC-deficient mice until now (see above;
11, 13). Using lung organ cultures we were able to show
that the number of branches was reduced by 36–46% in
homozygote TNC-deficient lung explants as compared with
wild-type controls (Figures 1–3, Table 1). In heterozygote
TNC-deficient lung explants half of the reduction was ob-
served (Figures 1 and 2, Table 1), predicting that not only
the presence of TNC, but also its amount is important. These
results represent the first mammalian TNC null phenotype,
where a developmental process caused structural alter-
ations.
However, it may be argued that lung organ cultures are
only in vitro studies. Therefore, we investigated the lung
at Postnatal Day P2. At this time point branching morpho-
genesis is completed and septation (alveolarization) has not
yet started (3). Volumetric comparison of TNC-null and
wild-type lungs did not reveal any significant difference for
either total or specific lung volume (Table 2). Based on
morphologic observations and on the estimation of the
mean volume-weighted airspace volume, the airspaces of
the lung parenchyma appeared to be almost two times larger
in TNC-null lungs than in the wild-type ones (see Results
and Figure 6). Because we did not observe any alteration
of the nonparenchymal structures in TNC-deficient lungs,
we conclude that the enlarged airspaces of the TNC-null
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lungs represent the result of a reduced branching of the
bronchial tree in the knockout mice. These morphologic in
vivo observations are supported by our in vitro data. We
measured the size of the terminal endbuds and were able
to show that especially those endbuds were enlarged that
did not branch during the observation period of 25 h
(Figure 4). This result represents further evidence that TNC
deficiency leads to an inhibition of branching, but not to
an inhibition of growth of the epithelial tubules (Figures 1,
2, and 4).
Our results reflect previously reported perturbation ex-
periments using anti-TNC antibodies and bacterially ex-
pressed TNC fragments in rat lung organ cultures. Young
and coworkers (16) described reduced branching, enlarged
terminal buds, and unaltered explant growth after perturba-
tion. Therefore, the lung represents one of the very few
examples where the results of perturbation experiments
correctly predicted a phenotype of the TNC-null mouse.
One reason for this result may be that the lung represents
one of the few organs in which TNC is more abundant than
tenascin-X (7).
During branching morphogenesis TNC is expressed at
the epithelial–mesenchymal interface and accumulates at
the growing tips of the bronchial tree where airway subdivi-
sion takes place (15, 16, 32). This zone is characterized by
an intensive and specific epithelial cell proliferation and
migration (33). As a multifunctional protein, TNC is in-
volved in processes like cell proliferation and migration
(13). Because both cell proliferation and cell death were
not significantly altered in the developing TNC-null lungs
(Figure 5), we hypothesize that TNC predominately influ-
ences cell migration, or more specifically the penetration
of the growing bronchial tip into the surrounding mesen-
chyme. In a growing organ, cleft formation (formation of
the branching point) is viewed as a spot where the epithelial
cells of the growing tip stop moving, while their neighbors
continue their penetration into the mesenchyme. Therefore,
we further hypothesize that TNC also takes part in the
control of cleft formation. This view is supported by our
observation that the terminal ends of the bronchial tree
are enlarged in TNC-null lungs throughout development
(Figure 4).
Proper lung development is highly sensitive to mechani-
cal stimuli and pressure. Fetal breathing movements (34, 35)
and spontaneous contractions of the future airways are im-
portant for proper lung development (23, 36). A compres-
sion of the lung, as occurred in oligohydraneous fetuses,
impairs lung development (37). The expression of TNC at
the terminal ends of the growing bronchial tree correlates
with mechanical stimuli (15, 16, 32). Both fetal breathing
movements (38) and spontaneous contractions of the future
airways (23) are extending the terminal buds rhythmically.
Our observed reduction of the number of branches in TNC-
null lungs lets us speculate that TNC may be one of the
factors transducing mechanical stimuli into cellular be-
havior.
In summary, we were able to describe the first develop-
mental phenotype of the TNC-null mouse that causes struc-
tural alterations of an organ. Most likely TNC contributes
to lung branching morphogenesis by the control of cell
migration during growth of the terminal endbuds and during
cleft formation. Furthermore, it may take part in the trans-
duction of important mechanical stimuli acting on the ter-
miends of the growing bronchial tree.
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